Importance Hepatocellular carcinoma (HCC) is the sixth most common malignancy and
fourth leading cause of cancer-related death worldwide. Recent advances in systemic and …

Background CEUS LI-RADS and CT/MRI LI-RADS have been used in clinical practice for
several years. However, there is a lack of evidence-based study to compare the proportion …

Background Liver Imaging Reporting and Data System (LI-RADS) was designed for contrast-
enhanced US (CEUS) with pure blood pool agents to diagnose hepatocellularfcarcinoma …

Background A simplification of the Liver Imaging Reporting and Data System (LI-RADS)
version 2018 (v2018), revised LI-RADS (rLI-RADS), has been proposed for imaging-based …

Please see the Editorial Comment by Kevin G. King discussing this article. BACKGROUND.
Contrast-enhanced ultrasound (CEUS) LI-RADS version 2017 (v2017) applies only to CEUS …

Please see the Editorial Comment by Jordan Swensson, discussing this article.
BACKGROUND. Previously proposed modifications to LI-RADS criteria for contrast …

Background LIRADS version 2018 (v2018) is used for noninvasive diagnosis of
hepatocellular carcinoma (HCC). A recently proposed modification (known as mLIRADS) …

Conversion Strategy for LI-RADS Category 5 Observations feature. Until version 2017,
assignment of feature threshold growth could be made based on any of the following: at …

Background Until now, there has been no systematic review or meta-analysis of direct head-
to-head studies that compare two liver imaging reporting and data system (LI-RADS) …

Background. This study aims to evaluate the application of dualenergy computed
tomography (DECT) for multiparameter quantitative measurement in earlystage …